Zhejiang Xinguang Pharmaceutical (300519) Revenue Breakdown - Main Composition

15.33
-0.52-3.28%

Market Closed Mar 20 15:00 CST

2.45BMarket Cap42.35P/E (TTM)

Zhejiang Xinguang Pharmaceutical (300519) Revenue Breakdown Overview

By Product

Currency:CNY

2025/H1

Stock NameRevenueRatio

Huangqi Shengmai decoction98.44M69.84%

Panax quinquefolium oral liquid28.13M19.96%

Shenjindan capsule11.8M8.38%

Other products2.5M1.78%

Other business60.2K0.04%

By Industry

Currency:CNY

2024/FY

Stock NameRevenueRatio

Pharmaceutical industry267.66M100.00%

By Country/Region

Currency:CNY

2025/H1

Stock NameRevenueRatio

Zhejiang Province127.92M90.76%

Zhejiang Province12.99M9.21%

Total special adjustments35.11K0.02%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Recently, the ongoing conflict between the US and Iran has continued to unsettle the stock market. On March 20, reports indicated that the T Show More

富哥搞钱

Feb 28 17:22

Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.